June 26, 2024 – Page 2 – Goldea Capital

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM

Written by Customer Service on June 26, 2024. Posted in Public Companies.

Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Majority of patients in this age group with eosinophilic esophagitis receiving Dupixent achieved histologic remission, with improvements sustained up to one year Dupixent is the first-and-only medicine indicated for eosinophilic esophagitis in the US for this age group Paris and Tarrytown, NY, June 26, 2024. The New England Journal of Medicine has published results from a positive phase 3 study of Dupixent (dupilumab) in children aged one to 11 years with eosinophilic esophagitis (EoE). The study showed a greater proportion of those receiving weight-tiered higher dose Dupixent experienced significant improvements in many key disease measures of EoE, compared to placebo at week 16. Data from the study were the basis for the...

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

Written by Customer Service on June 26, 2024. Posted in Public Companies.

Ohtuvayre is indicated for the maintenance treatment of COPD allowing for broad use in COPD patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects Conference call tomorrow at 8:30 a.m. EDT / 1:30 p.m. BST LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvayre is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years. Ohtuvayre is a first-in-class selective dual inhibitor of the enzymes phosphodiesterase 3 and phosphodiesterase 4 (“PDE3 and...

OV Entertainment Group Acquires Brazilian Studio Kokku Games and Argentinian Studio 3OGS

Written by Customer Service on June 26, 2024. Posted in Mergers And Acquisitions.

Merging Kokku’s co-development expertise and 3OGS engineering and porting talents under one roof LONDON, June 26, 2024 (GLOBE NEWSWIRE) — OV Entertainment Group, a newly formed UK-based global multimedia entertainment company, encompassing games, film/TV, and advertising industries, has finalized two strategic acquisitions in Latin America and Europe. The company has emerged as a significant player in the global cross-media market with its recent purchase of Brazil and Portugal-based Kokku, a leading AAA co-development studio, and 3OGS, a highly experienced tech and tools studio based in Argentina. Expanding Our Horizons: Strategic Acquisitions in Latin America and Europe Kokku, boasting a workforce of over 170 highly talented individuals and offices in Brazil and Portugal, has become a flagship addition to OV Entertainment’s portfolio....

Oragenics, Inc. Announces Closing of Public Offering

Written by Customer Service on June 26, 2024. Posted in Public Companies.

SARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced the closing of its public offering of 1,100,000 shares of its common stock at an offering price of $1.00 per share. The gross proceeds of the offering are approximately $1.1 million before deducting placement agent fees and other estimated offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to fund the continued development of its ONP-002 product candidate and for general corporate purposes and working capital. Dawson James Securities, Inc. acted as the sole placement agent for the offering. Shumaker, Loop & Kendrick, LLP, represented the Company in connection...

Applications Now Open for HII’s Ingalls Shipbuilding STEM Grant Awards

Written by Customer Service on June 26, 2024. Posted in Public Companies.

PASCAGOULA, Miss., June 26, 2024 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Ingalls Shipbuilding division announced today that the application period for its annual science, technology, engineering and mathematics (STEM) grant awards are now open for the 2024 -2025 academic school year and will remain open until Friday, October 18. Up to $100,000 in grants will be awarded and recipients will be announced during a ceremony at Ingalls in January 2025. These grants will support STEM-related initiatives at schools and educational organizations across Alabama, Louisiana and Mississippi. The photo accompanying this release is available at: https://hii.com/newsroom/. “We encourage educators to apply and share how Ingalls can support their students in pursuing STEM careers,” said Ingalls Shipbuilding Corporate Stewardship & Community...

Erik Fällström has decided to resign as board member of Anoto

Written by Customer Service on June 26, 2024. Posted in Public Companies.

Stockholm, 26 June 2024 Erik Fällström has decided to resign as board member of Anoto Anoto Group AB (publ) (“Anoto” or the “Company”) announces that Erik Fällström today has informed the Board of Directors of his decision to resign as board member of Anoto with immediate effect. The Board of Directors has resolved that deputy board member Alexander Fällström shall participate as board member in the Board of Directors for the period until the next Annual General Meeting to be held on 15 July 2024. For further information, please contact: Kevin Adeson, Chairman of the board of Anoto Group AB (publ) For more information about Anoto, please visit www.anoto.com or email ir@anoto.com Anoto Group AB (publ), Reg.No. 556532-3929, Flaggan 1165, 116 74 Stockholm About Anoto Group Anoto is a publicly held Swedish technology company known globally...

CVB Financial Corp. Announces 139th Consecutive Quarterly Cash Dividend

Written by Customer Service on June 26, 2024. Posted in Dividend Reports And Estimates.

ONTARIO, CA, June 26, 2024 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the second quarter of 2024. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on June 26, 2024. The quarterly dividend will be payable on or about July 25, 2024 to shareholders of record as of July 11, 2024. “We are pleased to announce our 139th consecutive quarterly cash dividend paid to our shareholders,” said David A. Brager, President and Chief Executive Officer. Corporate OverviewCVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank holding companies headquartered in California with approximately $16 billion in total assets. Citizens Business Bank is consistently...

Reborn Coffee Intends to Appeal Delisting Notice from Nasdaq

Written by Customer Service on June 26, 2024. Posted in Public Companies.

BREA, Calif., June 26, 2024 (GLOBE NEWSWIRE) — Reborn Coffee Inc. (Nasdaq: REBN), (“Reborn”, or the “Company”), a California-based retailer of specialty coffee, today announced that it has received a notice of delisting from Nasdaq. On June 21, 2024, Reborn Coffee (the “Company”) received a staff determination letter (the “Letter”) from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because it has not yet filed its Form 10-Q for the fiscal year ended March 31, 2024 (the “Filing”), it has failed to comply with the filing requirement set forth in Listing Rule 5250(c.)(1). As previously announced on May 15, 2024, the Company was required to dismiss BF Borgers CPA PC as the Company’s independent registered public accounting firm. The Company was required to...

Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges

Written by Customer Service on June 26, 2024. Posted in Public Companies.

Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0) Million to $0.0 Million NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the appointment of Arturo (Arty) Rodriguez as Chief Executive Officer (previously the Company’s Co-CEO and CFO) and Josh Feldman as Chief Financial Officer (previously the Company’s SVP of Finance) and that Joe Risico has resigned as Co-CEO and from the Board of Directors and will consult the Company over a three month transition period. “On behalf of our Board of Directors, we express our deep gratitude for Joe’s passion, innovative ideas, and relentless work ethic....

Concentrix Reports Second Quarter 2024 Results

Written by Customer Service on June 26, 2024. Posted in Earnings Releases And Operating Results.

Exceeds revenue expectations and raises full year 2024 revenue guidance reflecting solid demand for the Company’s differentiated technology and service offerings Generates over $200 million of adjusted free cash flow in the quarter and confirms adjusted free cash flow outlook for the year Returns $60 million to shareholders in the second quarter through share repurchases and dividends Reiterates its commitment to share repurchases, dividends and debt reduction in 2024 NEWARK, Calif., June 26, 2024 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal second quarter ended May 31, 2024. Three Months Ended May 31, 2024 May 31, 2023 Change Revenue ($M) $ 2,380.7 $ 1,614.7 47.4 % Operating income ($M) $ 150.2 $ 162.6 (7.6)% Non-GAAP...

Day: June 26, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice